Skip to main content

Cancer Care Efficiency

A path from evidence to implementation

Webinar I 25 October 2022 I 11:00 - 12:15 CEST

 

Inefficient cancer care can be a leading factor in poorer outcomes for patients. Building efficiency in cancer care requires health systems to operate as highly effective, evidence-based and data-driven learning systems. Yet, this cannot be achieved without a coordinated effort to eliminate the existing fragmentation of data, data silos and metrics.

A standard set of evidence-based metrics from which systems can choose, according to their specific needs and circumstances, can help to build system efficiencies. The All.Can International Cancer Efficiency Metrics Study published in June 2022, presents an evidence-based suite of cancer care efficiency metrics identified through a robust evidence review and stakeholder interviews.

These metrics can be applied by stakeholders across the cancer care continuum to consistently assess, benchmark and improve efficiency in cancer care. By using the Efficiency Metrics study as an example, this webinar will explore how evidence-based measures can be implemented in the real world, what disruptions exist, and how to overcome these in order to ultimately improve health outcomes for patients and society. Where do we need to start from? What kind of support do we need from health policy-makers?

The webinar is organised in close cooperation between EHFG and All.Can International,  supported by Bristol-Myers SquibbIf you have any questions for the speakers, ask them during registration, during the event via the webinar Q&A function, via email to info@ehfg.org or tweet @GasteinForum with #CancerCare. 

Details

Start: October 25, 2022
11:00 AM (UTC/GMT +01:00 - Europe / Vienna)
End: October 25, 2022
12:15 PM (UTC/GMT +01:00 - Europe / Vienna)
European Health Forum Gastein

Online event

Speakers

Nicoleta Antone

Head of Breast Cancer Center
Cancer Institute Ion Chiricuta
Nicoleta Antone

Bryan Bennett

Director Worldwide HEOR and Patient Reported Outcomes for Oncology
Bristol Myers Squibb
Bryan Bennett
  • Bryan Bennett

    Bryan Bennett, PhD CPsychol AFBPpS

    Bryan is currently a Director in the Patient Reported Outcomes Assessment, World Wide Health Economics and Outcomes Research at Bristol Myers Squibb, focussing on developing Clinical Outcomes Assessment strategies for oncology clinical trials. He has more than 20 years experience in clinical outcomes assessments within the pharmaceutic industry, consulting, academia and clinical practice. A key part of his research is ensuring that the patient voice is heard in clinical trials to understand how a patient feels and functions when taking treatment for cancer. He is passionate about health-related quality of life research and has published widely in the area. Bryan is a Chartered Psychologist and Associate Fellow and the British Psychological Society and Chair Elect of the Clinical Outcomes Assessment Special Interest Group of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).   

    Read more

Erik Briers

Vice chair
Europa Uomo
Erik Briers
  • Erik Briers

    Dr ERIK A.M. BRIERS MS PhD

    PhD in science, chemistry from the University of Leuven, Belgium. Since his promotion in 1979 he has been involved in laboratory medicine.

    He founded in 1982 the diagnostic company Eco-Bio diagnostics and developed a diagnostic test for the detection of Aspergillus antigens, this test has been approved by the FDA.

    He has been a guest lecturer at the University of Leuven 2009-2016.

    Erik Briers was the Executive Director of the European Cancer Patient Coalition (ECPC) (2012-2013) and ad interim executive director of EPPOSI.

    He was alternate patient member of the Committee on Advanced Therapies (CAT) (2016-2019), at the EMA.

    He is vice chair of Europa Uomo, the European Prostate Cancer Coalition, and Us Too Belgium.

    He is a member of the Guidelines Committee on the treatment of prostate cancer of the European Association of Urology (EAU) since 2013.

    Read more

Matt Hickey

CEO
The Health Value Alliance
Matt Hickey
  • Matt Hickey

    Matt is a Senior Medical Radiation Therapist, former Head of Cancer & Transformation for AXA Health UK, a board-level director and founder of the Health Value Alliance (HVA), a company focussed on delivering a new global Performance Indicator for assessing cancer quality, outcomes and value.

    In addition, Matt is co-chair of the All.Can International Research and Evidence Working Group and co-author of the All.Can Cancer Data and Cancer Efficiency Metrics reports.

    Matt is also a renowned international speaker on Outcomes and Value-Based Healthcare and is visiting lecturer on the University Cite Paris School of Medicine VBHC graduate programme.

    Matt co-sponsors a number of cancer outcomes research programmes and is a director or advisor to a number of start-up med-tech and med-services companies.

    Prior to AXA, Matt was International Director of Strategy and Health Economics for GenesisCare, Cancer Manager for Bupa UK, and a specialist consultant to Vitality Health UK and Southern Cross Health Society NZ, amongst others.

    Matt has a particular interest in developing global quality standards and on advancing the field of AI-supported predictive modelling in cancer.

    Read more

Niek Klazinga

Head of Health Care Quality Indicator Programme
OECD
Niek Klazinga
  • Niek Klazinga

    Niek Klazinga is a medical doctor by training, professor of social medicine at the Academic Medical Centre at the University of Amsterdam since 1999 and has been coordinating the Health Care Quality and Outcomes work of the OECD in Paris since 2007 till September 2022. Over the past 25 years, Niek has been involved in numerous projects and publications on quality in health care in The Netherlands and abroad. Recent activities include involvement in the OECD work on cancer care, running an EU funded international training network on performance intelligence in healthcare, member of the Dutch Quality Council (ZiN) and advisor to WHO and WB.

    Read more

Virpi Sulosaari

President Elect
The European Oncology Nursing Society
Virpi Sulosaari
  • Virpi Sulosaari

    Dr (PhD) Virpi Sulosaari has a nursing background. She has spesialised on hematology nursing and worked many years in hematology and oncology units in university hospitals. Sulosaari did her master and doctoral degree in nursing science. Currently, she is a principal lecturer in the Professional Master School of Health and Well-being in Turku University of Applied Sciences, Finland. She is also post-doctoral researcher in University of Turku, Finland. She is involved in several national and international projects including project focusing on inter-specialty training in oncology. Her expertise fields are related to cancer nursing, palliative care and under- and postgraduate nursing education. She is the current President Elect of the European Oncology Nursing Society (EONS).

    Read more

Moderation: Mark Lawler

Board Member
European Cancer Organisation
Moderation: Mark Lawler

Partners

All.Can International

Detected timezone